Healthcare - Sector
Adamas Pharmaceuticals's activity chart (see below) currently has 72 price targets and 64 ratings on display.
Analysts' price targets on this stock were met 39.96% of the time, taking 163.62 days on average.
Most recent stock forecast was given by from NORTHLAND CAPITAL MARKETS on 18-Nov-2021. First documented stock forecast 05-May-2014.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 29-Nov-2017
$8.5
5 years 1 days ago
(18-Nov-2021)
0/3 (0%)
$0.33 (4.04%)
Buy Since 17-Aug-2017
5 years 1 months 6 days ago
(13-Oct-2021)
3/7 (42.86%)
$9.25 (194.74%)
87
Hold Since 13-Oct-2021
$8
$10
5 years 1 months 6 days ago
(13-Oct-2021)
1/7 (14.29%)
$-0.07 (-0.87%)
6
Buy Since 12-Jan-2016
$8
$7
5 years 1 months 6 days ago
(13-Oct-2021)
4/5 (80%)
$-0.07 (-0.87%)
95
Buy Since 12-Nov-2018
$8
$20
5 years 1 months 7 days ago
(12-Oct-2021)
1/2 (50%)
$-0.08 (-0.99%)
7
What is ADMS (Adamas Pharmaceuticals) average time for price targets to be met?
Which analyst most recently updated their price target on ADMS (Adamas Pharmaceuticals)?
Which analyst has the most public recommendations on ADMS (Adamas Pharmaceuticals)?
Which analyst is the currently most bullish on ADMS (Adamas Pharmaceuticals)?
Which analyst is the currently most reserved on ADMS (Adamas Pharmaceuticals)?